ENTITY

Gain Therapeutics (GANX US)

Health CareUnited States
Gain Therapeutics, Inc. aspires to redefine drug discovery with its proprietary target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding.
more
Company Presentation05 May 2026 19:00
Company Presentation08 Apr 2026 19:00
Company Presentation08 Mar 2026 19:00
No more presentations
x